Malignant Colon Neoplasm — Trials

Malignant Colon Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 117
Ph III recruiting: 18
Growth YoY: −3.8%
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 26.9%
Trials / 1,000 deaths: 5.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (139)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02891538	Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients	completed	Early Phase 1	51	The University of Texas Health Science Center at San AntonioOTHER	1	Jun 30, 2026	clinicaltrials
NCT05658263	Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet	completed	Early Phase 1	14	University of MinnesotaOTHER	1	May 13, 2025	clinicaltrials